A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility

NCT03065959 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

42

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy determined at interim analysis

Conditions

Mobility Limitation

Interventions

DRUG: reldesemtiv
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]